Greg Richard from New York, NY, Class of 1988 and a member of the Delta Tau Delta fraternity, will receive the Lifetime Alumni Achievement Award given at a special Alumni Honors Convocation Ceremony to be held at 10:30 a.m., April 23, during Alumni Weekend in the Church of St. Mary the Virgin, Aldermanbury on the Westminster College campus in Fulton, MO.
Richard is Senior Vice President and General Manager of Interpace Diagnostics (IDXG: NASDAQ). He has had an exemplary career in the healthcare industry and is well regarded as a national subject matter expert in the field of healthcare reimbursement and innovative product commercialization.
The Lifetime Alumni Achievement Award is presented annually to alumni whose accomplishments reflect the Westminster mission and who have distinguished themselves through personal achievements, professional achievements and /or have made significant contributions to society. The award is approved by the Alumni Council and requires a motion and vote from the Board of Trustees for approval. Up to six alumni can receive the award annually.
“Westminster taught me to be open to new and different experiences, something that has been essential in our rapidly changing world,” says Richard. “In addition, the many friendships established, not just with my fellow students, but members of the faculty and staff, have endured for many years and continued to provide encouragement and support both professionally and personally. Westminster was a microcosm for the larger world in which I found myself following graduation and thanks to the dedication of countless people, I was ready.”
In his current role Richard was responsible for the launch of novel Molecular Diagnostic tests for pancreatic, thyroid and esophageal cancers.
He is a frequent speaker at healthcare industry conferences. Greg has authored and been featured in several articles in pertinent industry journals including Forbes, Kiplinger’s, G-2 Laboratory Industry Report, Managed Care Outlook, Centerwatch, Who’s Who in Medicine and Healthcare and Applied Clinical Trials.
Many Fortune 500 companies, including large Laboratory, Pharmaceutical, and Diagnostics organizations have hired Richard to ensure the successful launches of innovative technologies that better diagnose and treat patients with a wide variety of diseases. He has lead international organizations and managed staffs in eight different countries.